Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gynecology · Genitourinary Syndrome of Menopause

Can Low Estrogen Look Like Vaginal Leukoplakia or VaIN?

At a Glance

Low estrogen during menopause can make the vaginal lining generally pale, dry, and fragile, but a localized or persistent white patch can also be leukoplakia or an abnormal-cell condition called VaIN. Because appearance alone cannot distinguish them, clinical evaluation and sometimes biopsy are needed.

In this answer

4 sections

01

Understanding Low Estrogen Changes (GSM)

02

What Are Leukoplakia and VaIN?

03

How Your Doctor Investigates

04

Estrogen Therapy and Next Steps

Yes, low estrogen can cause the vaginal tissues to become pale or white, but a persistent white patch requires careful evaluation to ensure it is not a different condition. Finding a white spot in the vagina can be frightening, especially if you hear terms like “precancerous,” but a white patch is not the same as cancer. It is simply a visual finding, and proper evaluation is how the true cause is determined.

Understanding Low Estrogen Changes (GSM)

During menopause, the drop in estrogen can lead to Genitourinary Syndrome of Menopause (GSM), sometimes called vaginal atrophy [1]. Without sufficient estrogen, the vaginal lining becomes pale, dry, and fragile, and loses its normal natural folds, known as rugae [2][3]. GSM typically causes a generalized or widespread paleness across the vagina, often accompanied by bothersome symptoms like burning, irritation, and tissue that tears easily [4][1].

What Are Leukoplakia and VaIN?

It is important to understand that leukoplakia is not a specific disease. It is just a descriptive medical term for a white plaque or patch on the tissue. A white patch can have many causes, including benign (harmless) conditions, localized low estrogen effects, or abnormal cells [5].

VaIN (Vaginal Intraepithelial Neoplasia) is a specific diagnosis made when abnormal cells are found in the vaginal lining. VaIN is graded based on its severity (such as low-grade or high-grade), and not all VaIN has a high potential to become cancer. While VaIN can sometimes look like a distinct, raised, or persistent white plaque, it can also be flat, subtle, or difficult to see [6][7].

Because both low estrogen and VaIN can cause color changes in the tissue, visual appearance alone cannot reliably tell the difference between the two [8][9].

How Your Doctor Investigates

If you have a visible white patch or unexplained vaginal symptoms, your healthcare provider will use a few steps to determine the cause. Other underlying vaginal conditions must be ruled out before assuming that tissue changes are solely due to menopause [10].

  • Cytology and HPV Testing: Your doctor may take a swab of the vagina to check for abnormal cells and high-risk HPV. While high-risk HPV testing is useful for assessing risk, a positive result does not automatically mean you have VaIN, and a negative result does not completely rule out a lesion [11][12].
  • Colposcopy: A clinician uses a magnifying instrument with a light (a colposcope) to examine the vaginal walls closely. This helps identify the most suspicious areas by looking for abnormal patterns in the tissue or blood vessels [6][7].
  • Targeted Biopsy: If a distinct, persistent, or suspicious area is found, a targeted biopsy is the standard way to make a diagnosis [5]. This involves removing a tiny tissue sample so a pathologist can look for abnormal cells under a microscope. Sometimes multiple biopsies are needed to ensure the area is accurately assessed and that high-grade disease is not missed [13][14].

Estrogen Therapy and Next Steps

Local vaginal estrogen is a highly effective treatment for the dryness and widespread paleness of genuine GSM [15][16]. If your doctor diagnoses typical GSM and there are no suspicious focal areas, estrogen therapy can often be safely discussed and started [17].

However, estrogen should not be used as a “test” to see if a specific, suspicious white plaque goes away. Treating the vagina with estrogen might improve the surrounding atrophic tissue, but it leaves any potential underlying abnormal lesion unassessed [10].

When to Seek Care: If you have a localized, thickened, or persistent white patch—or if you experience unexplained bleeding, bleeding after sex, a sore, or significant pain—do not self-treat with over-the-counter moisturizers or assume it is just menopause. Arrange a clinical exam to ensure the area is properly evaluated.

Common questions in this guide

Can menopause cause a white or pale vaginal appearance?
Yes. Low estrogen during menopause can cause Genitourinary Syndrome of Menopause, which usually produces widespread vaginal paleness along with dryness, burning, irritation, and fragile tissue. A single persistent or thickened white patch is different and should be evaluated rather than assumed to be atrophy.
What does vaginal leukoplakia mean?
Vaginal leukoplakia is a descriptive term for a white plaque or patch, not a diagnosis by itself. The patch may be harmless, related to localized low estrogen, or associated with abnormal cells such as VaIN, so persistent or suspicious areas may need a biopsy.
Can a doctor tell vaginal atrophy from VaIN by looking at it?
Not reliably. Low-estrogen changes and VaIN can both alter vaginal color, so clinicians may use cytology, high-risk HPV testing, colposcopy, and a targeted biopsy when an area is persistent or suspicious.
Does a positive HPV test mean that I have VaIN?
No. A positive high-risk HPV result can raise concern and help assess risk, but it does not by itself diagnose VaIN. A negative result also cannot completely rule out a lesion, so the examination and other testing still matter.
Can vaginal estrogen be used to see whether a white patch is caused by menopause?
Vaginal estrogen should not be used as a test for a specific unexplained or suspicious patch. It can improve the widespread dryness and paleness of confirmed Genitourinary Syndrome of Menopause, but a focal lesion still needs appropriate clinical assessment.
When should I get a vaginal white patch checked?
Arrange a clinical examination for a localized, thickened, or persistent white patch, especially if you have unexplained bleeding, bleeding after sex, a sore, or significant pain. Do not assume the finding is caused by menopause or rely only on over-the-counter moisturizers.
Can vaginal atrophy and VaIN occur at the same time?
Yes, menopausal atrophy and a separate vaginal lesion can coexist. Treating low-estrogen symptoms does not rule out VaIN or another cause of a focal patch, so persistent or suspicious findings need evaluation.

Related questions

What Causes a Persistent White Vaginal Patch Besides HPV? Can Pap or HPV Diagnose Vaginal Leukoplakia Without Biopsy? Can the HPV Vaccine Help After VaIN or Vaginal Leukoplakia? Can Vaginal Lichen Planus and HPV-Related VaIN Coexist? Does Hysterectomy or Cervical Precancer Raise VaIN Risk?
Show more
How Do Smoking and Immunosuppression Affect VaIN Recurrence? How Is the Vaginal Leukoplakia Biopsy Site Chosen? How Often Is Vaginal Leukoplakia Cancer? Warning Signs Is Vaginal Leukoplakia a Diagnosis or a White Lesion? Is VaIN Contagious? HPV, Partner Testing, and Prevention What Are Red-Flag Symptoms of Invasive Vaginal Cancer? High-Risk HPV in VaIN: Can Testing Date the Infection? What Do p16, Ki-67, p53, and HPV Mean on a Pathology Report? What Do VaIN 1, 2, 3 and vLSIL/vHSIL Mean on Reports? Can a Benign Biopsy Miss a Persistent Vaginal White Patch? What If Vaginal Leukoplakia Pathology Is Inconclusive? Vaginal Leukoplakia Biopsy: What's Normal or an Emergency? What to Expect: Colposcopy & Biopsy for Vaginal Leukoplakia? What Symptoms Can Vaginal Leukoplakia Cause? Key Facts

Get notified when new evidence is published on leukoplakia of vagina.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study.

    Moral E, Delgado JL, Carmona F, et al.

    Climacteric : the journal of the International Menopause Society 2018; (21(2)):167-173 doi:10.1080/13697137.2017.1421921.

    PMID: 29411644
  2. 2

    The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece.

    Lambrinoudaki I, Mili N, Augoulea A, et al.

    Climacteric : the journal of the International Menopause Society 2024; (27(3)):289-295 doi:10.1080/13697137.2024.2314504.

    PMID: 38415685
  3. 3

    Criteria for Vaginal Atrophic Changes in Genitourinary Syndrome of Menopause Using Optical Coherence Tomography.

    Sirotina LZ, Potapov AL, Loginova MM, et al.

    Sovremennye tekhnologii v meditsine 2025; (17(2)):24-33 doi:10.17691/stm2025.17.2.03.

    PMID: 40416496
  4. 4

    Laser treatment for genitourinary syndrome of menopause: Scientific Impact Paper No. 72 (July 2022): Scientific Impact Paper No. 72 (July 2022).

    Phillips C, Hillard T, Salvatore S, et al.

    BJOG : an international journal of obstetrics and gynaecology 2022; (129(12)):e89-e94 doi:10.1111/1471-0528.17195.

    PMID: 35892242
  5. 5

    Abnormal Pap Smear and Diagnosis of High-Grade Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.

    Sopracordevole F, Mancioli F, Clemente N, et al.

    Medicine 2015; (94(42)):e1827 doi:10.1097/MD.0000000000001827.

    PMID: 26496321
  6. 6

    Colposcopic patterns of vaginal intraepithelial neoplasia: a study from the Italian Society of Colposcopy and Cervico-Vaginal Pathology.

    Sopracordevole F, Barbero M, Clemente N, et al.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(2)):152-157 doi:10.1097/CEJ.0000000000000287.

    PMID: 27428398
  7. 7

    Which Risk Factors and Colposcopic Patterns Are Predictive for High-Grade VAIN? A Retrospective Analysis.

    Iacobone AD, Radice D, Guerrieri ME, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(2)) doi:10.3390/diagnostics13020176.

    PMID: 36672986
  8. 8

    Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study.

    Monti E, Matozzo CMM, Cetera GE, et al.

    Anticancer research 2023; (43(10)):4637-4642 doi:10.21873/anticanres.16658.

    PMID: 37772563
  9. 9

    Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology on the Detection of Vaginal Intraepithelial Neoplasia.

    Zhou Q, Zhang F, Sui L, et al.

    Cancer management and research 2020; (12()):5987-5995 doi:10.2147/CMAR.S257875.

    PMID: 32765098
  10. 10

    Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.

    Pérez-López FR, Vieira-Baptista P, Phillips N, et al.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021; (37(8)):740-745 doi:10.1080/09513590.2021.1931100.

    PMID: 34036849
  11. 11

    Clinical characteristics and risk factors to high-grade vaginal intraepithelial neoplasia: a single-institution study.

    Lu M, Hong X, Liu T, et al.

    BMC women's health 2025; (25(1)):44 doi:10.1186/s12905-025-03585-7.

    PMID: 39893434
  12. 12

    Cytology and HPV Co-Testing for Detection of Vaginal Intraepithelial Neoplasia: A Retrospective Study.

    Stuebs FA, Dietl AK, Koch MC, et al.

    Cancers 2023; (15(18)) doi:10.3390/cancers15184633.

    PMID: 37760600
  13. 13

    Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia.

    He Y, Zhao Q, Geng YN, et al.

    Medicine 2017; (96(17)):e6700 doi:10.1097/MD.0000000000006700.

    PMID: 28445274
  14. 14

    Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study.

    Stuebs FA, Koch MC, Mehlhorn G, et al.

    Archives of gynecology and obstetrics 2020; (301(3)):769-777 doi:10.1007/s00404-020-05441-5.

    PMID: 31993733
  15. 15

    A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.

    Pickar JH, Amadio JM, Hill JM, et al.

    Menopause (New York, N.Y.) 2016; (23(5)):506-10 doi:10.1097/GME.0000000000000592.

    PMID: 26836245
  16. 16

    A Dermatologist's Approach to Genitourinary Syndrome of Menopause.

    Hum M, Dytoc M

    Journal of cutaneous medicine and surgery 2017; (21(5)):418-424 doi:10.1177/1203475417708165.

    PMID: 28453946
  17. 17

    Efficacy and Safety of Intravaginal Estrogen in the Treatment of Atrophic Vaginitis: A Systematic Review and Meta-Analysis.

    Ali A, Iftikhar A, Tabassum M, et al.

    Journal of menopausal medicine 2024; (30(2)):88-103 doi:10.6118/jmm.23037.

    PMID: 39315501

This page is for informational purposes only and does not constitute medical advice. A gynecologist should evaluate a persistent or suspicious vaginal white patch and determine whether HPV testing, colposcopy, or biopsy is appropriate.